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Objectives. Although small, the risk of rupture after EVAR remains a major concern. The aim of this study was to identify
mechanisms of late aneurysm rupture after endovascular repair.
Methods. Patients who suffered a proven aneurysm rupture after EVAR were identified from the EUROSTAR (European
Collaborators on Stent-graft Techniques for Abdominal Aortic Aneurysm Repair) registry. Complications preceding rupture
were studied to identify common patterns and possible mechanisms of late rupture.
Results. A rupture was documented in 34 patients resulting in death of 21 (62%). Adverse events documented during
previous follow-up in these patients included endoleak (30%), migration (18%), limb occlusion (12%) and kinking (12%).
The findings at time of rupture were documented in 24 patients and including endoleak: Type III (10), Type I (9), Type II (1);
stent-graft disintegration (2) and migration (3). Aneurysm diameter changes could be ascertained in 24 patients and had
increased in only seven.
Conclusion. The importance of graft-related endoleak, stent-graft disintegration and migration in the causation of
aneurysm rupture was confirmed. Poor compliance with follow-up schedule was also identified as a common feature.
However, the absence of complications in some patients, who attended regularly for follow-up, highlights the difficulty of
predicting rupture after EVAR.
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Introduction
Endovascular repair represents a major innovation in
the treatment of aortic aneurysm. Although the results
of randomised trials are awaited, there is compelling
evidence from case controlled and observational
studies that endovascular repair is associated with
shorter hospital stay and intensive care use and a
lower incidence of major morbidity and mortality in
the postoperative period compared to conventional
open surgery.1,2,3 However, aneurysm rupture during
follow-up after endovascular repair has been reported
regularly4,5,6 and such late failure of treatment remains
a major concern. It is seen by many as a limitation of
the endovascular technique. Since the primary pur-
pose of this operation is prevention of aneurysm
rupture and death, rupture of the treated aneurysm
represents unequivocal failure of treatment.
A better understanding of the mechanisms of stent-
graft failure leading to aneurysm rupture is imperative
for improvements in both stent-graft design and
surveillance protocols. The aim of this study was to
examine a series of patients enrolled in the EURO-
STAR (European Collaborators on Stent-graft Tech-
niques for Abdominal Aortic Aneurysm Repair)
registry who suffered a rupture despite implantation
of a stent-graft, in order to identify common features
and possible mechanisms of aneurysm rupture after
endovascular repair.
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Methods
EUROSTAR project
EUROSTAR project was launched in 1996 with the
objective of collating information on endovascular
treatment of aortic aneurysms. The project was set out
as a pan-European multi-center registry to allow the
collection of as much data as possible in as short a time
as possible for expeditious scientific evaluation of this
technique. Registration is done on an ‘intention-to-
treat’ basis and data is collected prospectively by
means of case record forms (paper or on-line format).
Preoperative evaluation, operative details and follow-
up data are collected. Follow-up protocol requires
patient assessment by contrast-enhanced CT scan at 1,
3 (optional), 6, 12 and 18 months after the operation
and yearly intervals, thereafter. The surveillance
protocol also includes clinical examination and an
annual plain abdominal X-ray study. The information
is stored on an ‘Oracle’ (Oracle Corporation, CA, USA)
based database for periodic analysis.
Patients
A total of 4291 patients from 113 centres in 17
European countries who were registered with the
registry by March 2002 were included in the analysis.
The median age of the patients was 71.8 years (37–
100.1) with a median aneurysm diameter of 5.5 cm (3–
14.5). Since new patients are continuously registered
with the database, the median follow-up duration was
modest at 12 months. However, follow-up data of at
least up to 2 years was available in 1520 patients, of
whom, 921 were followed-up for at least 3 years or
more.
Patients who were diagnosed with a rupture of the
treated aneurysm on the basis of CT scan findings,
outcome of open operation or autopsy were included
in this series. Patients with aneurysm rupture during
the initial endovascular repair and those who suffered
a sudden death without objective confirmation of
rupture were not included.
Results
By March 2002, a total of 34 patients were reported to
have ruptured their aneurysm after EVAR. The
median interval was 18 months after the initial
endovascular procedure. Freedom-from-rupture in
the entire cohort of 4291 patients that were expected
to undergo surveillance (rupture-free survival) is
presented in Fig. 1 as Life Table curve.
The patient characteristics are described in Table 1.
Preoperative aneurysm diameter, diameter at the last
follow-up, diameter at rupture and duration since the
last follow-up and duration since endovascular repair
are given in Table 2. Adverse findings noted during
Fig. 1. Life table of rupture-free survival in the entire EUROSTAR cohort of 4291 patients. Figures next to curve represent
number of patients at risk at each interval.
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the follow-up and at presentation with rupture are
presented in Table 3.
Adverse events during initial admission
A total of 25 (74%) patients were documented to have
suffered complications during the original operation or
the postoperative period. Six patients were noted to have
an endoleak (four with Type I and two with Type II
endoleak) at completion angiography (details in Table
3). Device or technique related complications, such as
difficulty with device release mechanisms or bursting of
angioplasty balloons etc. were reported in seven patients
(21%), but endovascular repair was successfully com-
pleted in all the patients. Inadvertent overlap of an
internal iliac artery was reported in two and intra-
arterial thrombosis of a lower limb was reported in a
further two patients. Postoperative complications
reported included temporary renal failure (5 patients)
Table 1. Patient and device details.
Characteristic Patients with a rupture
ðN ¼ 34Þ
Gender Male 31 (91.2%)
Female 3 (8.8%)
Age at operation (years) ,65 4 (11.8%)
65–74 14 (41.2%)
.74 16 (47.1%)
ASA grade I 3 (9.1%)
II 7 (21.2%)
III 19 (57.6%)
IV 4 (12.1%)
Device Aneurx 3 (8.8%)
EVT 1 (2.9%)
Excluder 1 (2.9%)
Stentor 9 (26.5%)
Talent 4 (11.8%)
Vanguard 15 (44.1%)
Zenith 1 (2.9%)
ASA, American Society of Anaesthesiologists.
Table 2. Aneurysm diameter and duration since endovascular repair in patients who suffered a late rupture.
Pt Maximum aneurysm diameter (mm) Duration to rupture since (months)
Pre-op At last follow-up At rupture Last follow-up Endovascular repair
1 50 38 5 41
2 75 90 29* 40
3 52 50 3 18
4 76 58 10 47
5 60 50 4 24
6 70 70 2 3
7 58 57 3 9
8 55 65 7 55
9 64 69 9 45
10 80 67 4 22
11 33† 14* 24
12 105 70 7* 9
13 6 12
14 55 31* 67
15 50 7* 18
16 69 63 1 3
17 50 62 16* 53
18 80 76 37* 40
19 69 71 4 18
20 81 81 86 8 21
21 55 47* 60
22 58 29* 51
23 72 106 53* 54
24 48 30 63* 64
25 50 53 4 18
26 50 50 6* 6
27 74 65 85 6 24
28 83 6* 6
29 85 90 89 11 47
30 59 55 5 15
31 55 44 4 10
32 64 78 78 5 20
33 61 1 18
34 94 93 1 1
*Non-compliance with follow-up appointments.
†Endovascular repair of aorto-iliac aneurysm with iliac component measuring 64 mm.
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Table 3. Adverse features noted during follow-up and at the time of rupture.
Pt Adverse features
At completion and follow-up At rupture
1 Stent-graft stenosis noted at 18 months Distal Type I endoleak
2 Type III endoleak at 1 month,
spontaneous resolution; distal Type I endoleak
at 12 months, corrected
Distal Type I endoleak
3 Type II endoleak noted at 3
and 6 months CT scans but
not at 12 months. Type III
endoleak at 12 month, not corrected
Type III endoleak
4 Migration at 3 months, decrease in
aneurysm diameter
Type III endoleak
5 Partial infarction of one kidney noted
at 6 months, exact cause not
clear
Type III endoleak
6 Migration and Type II endoleak noted
at 1 month
Type III endoleak
7 Unremarkable follow-up Proximal Type I endoleak
8 A thin layer of laminar thrombus
was noted lining the stent-graft
Distal Type I endoleak
9 Kinking of stent graft noted at
12 months, progressed to graft-stenosis by 24 months
Distal Type I endoleak
10 Migration at 12 months Not reported
11 Type II endoleak at completion. Patient
did not attend any follow-up
Not reported
12 Stent-graft kinking noted at 1 month,
patient did not attend further follow-up
Not reported
13 Migration, proximal Type I and Type
III endoleaks noted at 6 months
Not reported
14 Migration at 24 months treated by
a proximal cuff. Type III endoleak
at 36 months. Severe deterioration in
general health and further intervention or
follow-up was considered inappropriate
Not reported
15 Perianeurysmal fibrosis at one month, resolved
by 6 months. Stent-graft kinking was noted at 12
months
Severe structural disintegration of the device
16 Proximal Type I endoleak at completion,
unsuccessful treatment with Palmaz stent followed
by persistence of the endoleak
Proximal Type I endoleak
17 Proximal Type I endoleak at completion
with spontaneous thrombosis by 1 month.
However, a proximal cuff was placed
at three months Stent kinking and
a distal Type I endoleak were
noted at 18 months, treated by
secondary intervention. Normal findings at 24
and 36 months CT scans
Aneurysmal change of preoperatively normal common
iliac artery and rupture of common
iliac artery aneurysm
18 Distal Type I endoleak at completion
which spontaneously thrombosed by 1 month.
Left limb of device occluded by
thrombosis by 3 months following which
patient declined follow-up
Not reported
19 Severe angulation of the stent-graft at 12 months Severe structural disintegration and migration of
the device
20 Type II endoleak and increase in
aneurysm size noted at 12 months
Type II endoleak
21 Patient did not attend follow-up until 48 months at which
CT scan was normal
Type III endoleak
22 Patient did not attend follow-up until 48 months at which
CT scan was normal
Type III endoleak
23 Patient did not attend any follow-up Type III endoleak
24 Patient did not attend any follow-up Not reported
25 Unremarkable follow-up Not reported
26 Unremarkable follow-up Type III endoleak
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and sepsis (two patients). Access site hematoma or false
aneurysms was reported in 4 patients.
Compliance with follow-up schedule
EUROSTAR protocol of postoperative surveillance
including physical examination and contrast
enhanced CT examination, and annual plain abdomi-
nal radiography in two planes was due at fixed
postoperative times (see methods for schedule). This
cohort of patients was expected to have attended a
total of 197 follow-up visits according to EUROSTAR
protocol. However, only a total 140 visits were
recorded, including the admission at time of rupture.
Thirteen patients (38%) missed one or more follow-up
visits immediately prior to diagnosis of rupture
(patients are identified in Table 2 by an asterisk).
Adverse events during follow-up
Twenty patients (62%) had at least one complication
noted during follow-up before rupture occurred (Table
3). Fourteen (42%) of these patients had a complication
at the last follow-up visit before presentation with
rupture. In thirteen patients no complications were
reported during follow-up (until their admission at the
time of rupture). However, only five of these patients
were fully compliant with follow-up schedule. The
mean follow-up time before rupture in this group was
12 months (range 6–24 months).
An endoleak was documented at the time of the
rupture in 59 percent (20/34) of the patients. All but
one of these endoleaks were graft-related, nine
patients (26%) had a Type I and 10 (29%) had a Type
III endoleak. In 11.8 percent (4/34) of the patients, a
migration was reported. An adverse event (likely to be
associated with rupture) was documented in 20 of the
patients. In six of them the complication noted at the
time of rupture was already diagnosed at the last visit
preceding the rupture. In two patients an additional
complication was also recorded at the time of rupture
(patient number 9 and 30 from Table 3). One patient
had an uncorrected proximal Type I endoleak at
completion angiography and suffered rupture before
discharge following the original endovascular repair.
However, in the remaining 11 patients there was
undue delay present in their follow-up schedule. In
nine of these, the adverse event was observed at an
earlier visit, showing no abnormalities at the last pre-
rupture visit, and two had earlier observed adverse
events but missed later visits.
Treatment of the ruptured aneurysm
Aneurysm rupture was treated by conventional open
repair in 19 patients, nine of who survived. Endovas-
cular re-intervention was performed after the rupture
in seven patients, successfully in five but the remain-
ing two patients died immediately after the procedure.
In total, 21 patients died from aneurysm rupture by
March 2002.
Discussion
The mechanisms of aneurysm rupture after endovas-
cular repair need to be identified and understood
Table 3 Continued
Pt Adverse features
At completion and follow-up At rupture
27 Type II endoleak at 3 months,
persistent to 6 months with increase
in aneurysm diameter. Embolisation followed by
aneurysm shrinkage
Type III endoleak
28 Proximal Type I endoleak on pre-discharge CT, not treated. Did not
attend further follow-up
Proximal Type I endoleak
29 Unremarkable follow-up Migration and Type III endoleak
30 Reduction in diameter by 6 months.
Migration at 12 months followed by
increase in diameter
Kinking and distal Type I endoleak
31 Type II endoleak at completion and
unremarkable follow-up with reduction in diameter
Not reported
32 Type II endoleak noted at 1
month and not on further follow-up. Aneurysm size increased.
Minor suture
breakage
Not reported
33 Unremarkable follow-up Migration and partial occlusion of stent-graft with thrombosis
34 Uncorrected proximal Type I endoleak Proximal Type I endoleak
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better so that stent-graft design and surveillance
protocols can be improved. A previous analysis of
EUROSTAR database comparing the patients who
suffered a late rupture with the overall cohort without
aneurysm rupture, identified endoleak, graft
migration, and kinking as factors during follow-up,
to be significantly associated with late rupture after
endovascular repair.4 By identifying risk-factors, such
comparative analyses serve to establish the relative
importance of various complications noted during the
follow-up so that secondary interventions and sur-
veillance techniques can be modified appropriately. It
is likely that the incidence of actual aneurysm rupture
after endovascular repair in EUROSTAR patients is
higher than the incidence of reported rupture used for
present analysis. This is due to many difficulties in
confirming aneurysm rupture in a proportion of
patients, particularly those with sudden death. Fur-
thermore, variations in the severity of complications
and the effect of secondary interventions remain
uncertain factors in statistical analyses.
In this series of 34 patients, no complications were
identified prior to the diagnosis of a rupture in a
relatively large proportion of patients (39%). Five of
these patients were compliant with their follow-up
schedules. This illustrates the difficulty in predicting
failure of endovascular repair and the fact that all
patients with an endovascular repair remain at a risk
of late failure. It is possible that subtle abnormalities
might have been missed in imaging studies in these
patients but this cannot be confirmed or refuted due to
the absence of a core laboratory facility. An absolute
guarantee that rupture will not occur, cannot be given
to a patient after endovascular aneurysm repair.
Therefore, it is better to consider this treatment in
terms of reduction of the reduction of the rupture risk,
which is approximately 97 percent.6 Non-compliance
with standard follow-up schedule was also identified
as a common feature with nearly forty percent of
patients missing the routine follow-up imaging visits
immediately prior to the diagnosis of rupture. Poor
compliance with follow-up schedules had also been
identified by others as a contributory factor for late-
rupture7 and the ability and willingness of patients to
attend regular surveillance scans ought to be identified
when selecting patients for endovascular repair.
Type III endoleak, proximal or distal Type I
endoleak, and severe modes of structural disinte-
gration of stent-grafts with or without migration were
the most commonly documented findings at the time
of rupture. All of these factors may result in sudden
reperfusion of the aneurysm sac, subjecting it to
systemic blood pressure. There is a general consensus
that graft-related endoleaks have serious conse-
quences8 and the findings of this study reinforce the
importance of prompt treatment of such endoleaks.
Modular separation or defects in stent-graft fabric due
to material fatigue (Type III endoleaks) clearly
represent device failure and remain an issue for the
industry to implement necessary improvements in
stent-graft design. This adverse event was observed in
29 percent of the patients with rupture. Newer
generations of stent-grafts appear to be better in this
respect than the older generation but this remains to be
proven. Proximal or distal Type I endoleaks during
follow-up (observed in 26 percent of the study group)
occur due to a variable combination of features relating
to patient selection, post-operative morphological
changes of the aneurysm and stent-graft properties
and selection.
A reduction in the aneurysm diameter is generally
accepted to imply a reduction in the risk of rupture.
However, the majority of the patients (63% of the study
group) in whom it was possible to establish changes in
aneurysm diameter demonstrated either a reduction
or no significant change. An increase in aneurysm
diameter by 5 mm or more was documented in only
seven out of 24 patients, highlighting the limitation to
the use of aneurysm diameter changes alone as an
indicator of rupture risk.
The potential of isolated Type II endoleaks for
causing failure of endovascular aneurysm repair has
been shown to be low.9 However, one patient noted to
have a persistent Type II endoleak had an expanding
aneurysm (patient 20, Table 2). This patient was noted
to have no other complications when presenting with
aneurysm rupture. This observation emphasizes the
potential of a Type II endoleaks to cause rupture, albeit
rarely.
In conclusion, failure of endovascular aneurysm
repair detracts from the benefits conferred by this
technique in terms of reduced post-operative morbid-
ity and mortality. Examination of a series of patients
whose aneurysm ruptured after endovascular aneur-
ysm repair revealed: poor compliance with follow-up,
endoleaks, and stent-graft disintegration and
migration to be common features.
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